News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
157,817 Results
Type
Article (8585)
Company Profile (37)
Press Release (149195)
Multimedia
Podcasts (15)
Webinars (3)
Section
Business (47341)
Career Advice (277)
Deals (5920)
Drug Delivery (21)
Drug Development (22846)
Employer Resources (42)
FDA (2830)
Job Trends (3984)
News (78652)
Policy (5911)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (2)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (3)
2024 Genetown Standard (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (961)
Accelerated approval (1)
Adcomms (3)
Allergies (23)
Alliances (13022)
ALS (29)
Alzheimer's disease (565)
Antibody-drug conjugate (ADC) (22)
Approvals (2821)
Artificial intelligence (75)
Autoimmune disease (5)
Automation (5)
Bankruptcy (36)
Best Places to Work (3536)
BIOSECURE Act (2)
Biosimilars (21)
Biotechnology (24)
Bladder cancer (20)
Brain cancer (11)
Breast cancer (98)
Cancer (642)
Cardiovascular disease (76)
Career advice (255)
Career pathing (8)
CAR-T (42)
Cell therapy (121)
Cervical cancer (2)
Clinical research (17907)
Collaboration (241)
Compensation (40)
Complete response letters (4)
COVID-19 (768)
CRISPR (19)
C-suite (98)
Cystic fibrosis (37)
Data (791)
Denatured (8)
Depression (10)
Diabetes (71)
Diagnostics (1681)
Digital health (3)
Diversity, equity & inclusion (11)
Drug discovery (35)
Drug pricing (16)
Drug shortages (3)
Duchenne muscular dystrophy (35)
Earnings (12669)
Editorial (10)
Employer branding (10)
Employer resources (39)
Events (24587)
Executive appointments (249)
FDA (3117)
Featured Employer (15)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (246)
Gene editing (42)
Generative AI (8)
Gene therapy (95)
GLP-1 (194)
Government (1045)
Guidances (13)
Healthcare (4204)
Huntington's disease (3)
IgA nephropathy (5)
Immunology and inflammation (23)
Indications (8)
Infectious disease (808)
Inflammatory bowel disease (45)
Inflation Reduction Act (2)
Influenza (16)
Intellectual property (22)
Interviews (39)
IPO (2384)
IRA (8)
Job creations (662)
Job search strategy (231)
Kidney cancer (2)
Labor market (10)
Layoffs (96)
Leadership (5)
Legal (1004)
Liver cancer (15)
Lung cancer (85)
Lymphoma (40)
Machine learning (2)
Management (11)
Manufacturing (55)
MASH (22)
Medical device (1927)
Medtech (1930)
Mergers & acquisitions (3670)
Metabolic disorders (196)
Multiple sclerosis (23)
NASH (5)
Neurodegenerative disease (30)
Neuropsychiatric disorders (7)
Neuroscience (733)
NextGen: Class of 2025 (1445)
Non-profit (1480)
Northern California (681)
Now hiring (6)
Obesity (105)
Opinion (50)
Ovarian cancer (14)
Pain (20)
Pancreatic cancer (18)
Parkinson's disease (56)
Partnered (5)
Patents (45)
Patient recruitment (26)
Peanut (9)
People (19057)
Pharmaceutical (9)
Phase I (5424)
Phase II (7622)
Phase III (6174)
Pipeline (316)
Policy (38)
Postmarket research (704)
Preclinical (3361)
Press Release (33)
Prostate cancer (27)
Psychedelics (12)
Radiopharmaceuticals (57)
Rare diseases (118)
Real estate (1378)
Recruiting (17)
Regulatory (4372)
Reports (9)
Research institute (1069)
Resumes & cover letters (27)
Rett syndrome (1)
RNA editing (1)
RSV (6)
Schizophrenia (18)
Series A (60)
Series B (17)
Sickle cell disease (27)
Southern California (554)
Special edition (2)
Spinal muscular atrophy (66)
Sponsored (13)
Startups (1237)
State (1)
Stomach cancer (3)
Supply chain (9)
Tariffs (3)
The Weekly (7)
United States (5806)
Vaccines (150)
Venture capitalists (9)
Weight loss (50)
Women's health (8)
Worklife (2)
Date
Today (9)
Last 7 days (141)
Last 30 days (700)
Last 365 days (8939)
2025 (2431)
2024 (9584)
2023 (10904)
2022 (13893)
2021 (15167)
2020 (13647)
2019 (11381)
2018 (8656)
2017 (8509)
2016 (7978)
2015 (8814)
2014 (6458)
2013 (5155)
2012 (5328)
2011 (5562)
2010 (4667)
Location
Africa (178)
Alabama (13)
Alaska (4)
Arizona (32)
Arkansas (2)
Asia (9047)
Australia (1492)
California (1491)
Canada (550)
China (104)
Colorado (70)
Connecticut (72)
Delaware (34)
Europe (23189)
Florida (173)
Georgia (50)
Idaho (10)
Illinois (106)
India (2)
Indiana (62)
Iowa (1)
Japan (38)
Kansas (11)
Kentucky (4)
Louisiana (3)
Maine (38)
Maryland (194)
Massachusetts (1282)
Michigan (82)
Minnesota (63)
Missouri (20)
Montana (5)
Nebraska (6)
Nevada (14)
New Hampshire (14)
New Jersey (408)
New Mexico (21)
New York (504)
North Carolina (222)
North Dakota (2)
Northern California (681)
Ohio (66)
Oklahoma (6)
Oregon (19)
Pennsylvania (344)
Puerto Rico (2)
Rhode Island (14)
South America (210)
South Carolina (2)
Southern California (554)
Tennessee (18)
Texas (241)
Utah (65)
Virginia (31)
Washington D.C. (10)
Washington State (139)
Wisconsin (12)
157,817 Results for "cb scientific".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CB Scientific Inc. (CBSC) Formally Launches Next Generation MyCardia AT Cardiac Monitor
February 25, 2025
·
4 min read
BioMidwest
CB Scientific, Inc. Concludes its Annual Meeting of Stockholders
CB Scientific, Inc., a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products and services, announced that the company successfully concluded its Annual Meeting of Stockholders on Thursday, March 14, 2024 as planned.
March 19, 2024
·
3 min read
Business
CB Scientific, Inc. 2023 Year in Review
CB Scientific. Inc. today is providing its shareholders with a 2023 year-end review from Charles Martin, Chief Executive Officer.
January 11, 2024
·
7 min read
Press Releases
CB Scientific, Inc. Appoints Trip Thomas as Chief Financial Officer
October 3, 2024
·
2 min read
Press Releases
Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
March 28, 2025
·
4 min read
Press Releases
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Buy Rating With a Price Target of $14.00 From CB Capital Partners
March 5, 2025
·
6 min read
Press Releases
CB Scientific, Inc. Announces Voluntary Delisting from OTCQB Venture Market
August 21, 2024
·
2 min read
Press Releases
Skye Bioscience Demonstrates Prominent Role of Peripheral CB1 Inhibition and Achieves Significant Weight Loss with Novel CB1-inhibiting Antibody, Nimacimab, in Preclinical Model
November 5, 2024
·
5 min read
Lone Star Bio
NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield
NanoVibronix, Inc., a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave Portable Ultrasonic Therapeutic Devices, announced that it has entered into a distribution agreement with CB Medical, LLC for the sale and distribution of the Company’s UroShield.
May 14, 2024
·
5 min read
Weight loss
Can CB1 Inhibitors Make a Comeback in Obesity?
After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo Nordisk, Corbus Pharmaceuticals and Skye Bioscience are betting that a new mechanism of action will improve the safety profile.
October 7, 2024
·
6 min read
·
Jill Drachenberg
1 of 15,782
Next
